HFE rs1800098: Understanding the C282Y Variant
The rs1800098 variant, widely known as C282Y, is a specific change in the HFE gene that affects how the body regulates iron absorption. It is primarily associated with hereditary hemochromatosis, a condition where the body absorbs and stores excessive amounts of iron.
What each genotype means
Typical iron regulation
This genotype represents the wild-type or common form of the HFE gene. Individuals with this profile do not carry the specific variant associated with increased hereditary hemochromatosis risk at this position.
This is the most common genotype across all global populations.
Carrier of iron variant
You carry one copy of the H63D variant (c.187C>G, often referred to as H63D). While this variant is associated with hereditary hemochromatosis, it has very low penetrance, and most individuals with this genotype do not develop clinical iron overload without other contributing factors.
This genotype is relatively common in populations of European ancestry, appearing in a significant portion of the population.
Increased iron variant risk
You carry two copies of the H63D variant. While this genotype is associated with hereditary hemochromatosis, the clinical penetrance is low, and most individuals will not develop severe iron overload unless other comorbid factors like diabetes or high alcohol consumption are present.
This genotype is found in a smaller subset of the population compared to carriers, primarily observed in individuals of European descent.
What is rs1800098?
The variant rs1800098, frequently referred to in medical literature as C282Y, is a single nucleotide polymorphism (SNP) located within the HFE gene on chromosome 6. This specific genetic change involves a substitution where the amino acid cysteine is replaced by tyrosine at position 282 of the HFE protein. Because of its location and functional impact, this variant is the most well-studied genetic marker for hereditary hemochromatosis. It is important to note that while this variant is a significant focus of genetic research, it is just one of many variations that can occur within the human genome. Understanding this SNP requires looking at how it alters the structure of the protein it encodes and how that change influences the body's complex physiological processes regarding mineral homeostasis.
The Role of the HFE Gene
The HFE gene provides instructions for creating the hereditary hemochromatosis protein, which is a membrane protein that shares structural similarities with MHC class I molecules. Its primary function is to regulate the absorption of iron from the diet by interacting with other proteins on the surface of cells. By modulating these interactions, the HFE protein helps ensure that the body maintains appropriate iron levels. When the HFE gene contains the rs1800098 variant, the resulting protein may not function as intended, which can lead to a disruption in the body's ability to sense and control iron intake. This dysregulation is the underlying mechanism that can lead to the accumulation of iron in various tissues and organs over time, potentially causing health complications if left unmanaged.
Research and Clinical Associations
Research has established a strong association between the rs1800098 variant and hereditary hemochromatosis, particularly in individuals of Northern European descent. It is classified as an autosomal recessive condition, meaning that an individual typically needs to inherit the variant from both parents to be at the highest risk for clinical iron overload. However, the presence of this variant does not guarantee that an individual will develop the disease; this concept is known as incomplete penetrance. Many people who carry the variant never experience significant health issues. Current clinical guidelines emphasize that genetic testing for this variant should not be performed in the general population without a specific medical reason, such as clinical evidence of iron overload or a documented family history of the condition.
Population Frequency
The rs1800098 variant is most common in populations of Northern European ancestry, where it is considered the most frequent inherited disorder. In these groups, the prevalence of the variant is significantly higher compared to other global populations, where it is often rare or absent. For example, studies have shown that the frequency of the C282Y allele can vary widely even within Europe, ranging from approximately 1.3% in some Mediterranean regions to over 11% in parts of Ireland. Because of this ancestry-specific distribution, the clinical relevance of testing for this variant is often interpreted within the context of an individual's ethnic background and family history.
Managing Genetic Information
Information about your genetic variants should always be discussed with a qualified healthcare professional, such as a doctor or a genetic counselor. It is important to understand that having a specific genotype does not constitute a medical diagnosis. If you are concerned about your iron levels or have a family history of hemochromatosis, a clinician can order appropriate blood tests, such as serum ferritin and transferrin saturation, to assess your actual iron status. Never make changes to your diet, supplements, or medical care based solely on genetic test results without consulting your healthcare provider. Genetic data provides a piece of the puzzle, but clinical evaluation remains the gold standard for understanding your health and determining if any medical intervention is necessary.
How common is this variant?
The rs1800098 variant is common in European populations, with allele frequencies varying significantly by region, while it remains rare in many other global populations.
Frequently asked questions
Does having the HFE variant mean I have hemochromatosis?
No, having the variant does not mean you have the disease. Many people with the variant never develop iron overload, and clinical diagnosis requires blood tests to measure iron levels in the body.
Should I get tested for the HFE C282Y variant?
Genetic testing is generally recommended only for individuals with symptoms of iron overload or those with a first-degree relative diagnosed with hereditary hemochromatosis. You should discuss the necessity of testing with your doctor.
What is the difference between being a carrier and having the condition?
A carrier has one copy of the variant and is unlikely to develop the disease. Having the condition typically requires inheriting two copies of the variant, one from each parent.
Can I change my diet to manage this variant?
If you have been diagnosed with iron overload, your doctor may recommend specific dietary changes or medical treatments like phlebotomy. Do not alter your diet or take iron supplements based on genetic results without professional medical advice.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800098?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HFE
The Ser65Cys missense polymorphism in HFE linked to mild systemic iron regulation changes and downstream impacts on hypogonadotropic reproductive function.
The C282Y missense variant in HFE is the primary genetic cause of hereditary hemochromatosis, leading to iron overload.
Common HFE missense variant H63D associated with hereditary hemochromatosis and mild iron overload risk.
HFE p.His63Asp (H63D) variant contributing to hereditary hemochromatosis risk, especially in compound heterozygosity with C282Y.
Coding variant (p.Val162Met) in the homeostatic iron regulator gene studied alongside classical hemochromatosis variants.
Known as HFE S65C (c.193A>T), this missense variant is associated with mild variations in transferrin saturation and iron accumulation, often evaluated alongside C282Y and H63D.